118 related articles for article (PubMed ID: 37718485)
1. RNA-binding protein-regulated fibronectin is essential for EGFR-activated metastasis of head and neck squamous cell carcinoma.
Shieh JM; Chang TW; Wang JH; Liang SP; Kao PL; Chen LY; Yen CJ; Chen YJ; Chang WC; Chen BK
FASEB J; 2023 Oct; 37(10):e23206. PubMed ID: 37718485
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis
Hsu JY; Chang JY; Chang KY; Chang WC; Chen BK
FASEB J; 2017 Oct; 31(10):4265-4276. PubMed ID: 28596235
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor-induced cyclooxygenase-2 enhances head and neck squamous cell carcinoma metastasis through fibronectin up-regulation.
Hsu JY; Chang KY; Chen SH; Lee CT; Chang ST; Cheng HC; Chang WC; Chen BK
Oncotarget; 2015 Jan; 6(3):1723-39. PubMed ID: 25595899
[TBL] [Abstract][Full Text] [Related]
4. FUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR/ERK/STAT signaling pathway.
Wang Q; Liao C; Tan Z; Li X; Guan X; Li H; Tian Z; Liu J; An J
Cancer Gene Ther; 2023 Jan; 30(1):182-191. PubMed ID: 36151332
[TBL] [Abstract][Full Text] [Related]
5. PTX3 gene activation in EGF-induced head and neck cancer cell metastasis.
Chang WC; Wu SL; Huang WC; Hsu JY; Chan SH; Wang JM; Tsai JP; Chen BK
Oncotarget; 2015 Apr; 6(10):7741-57. PubMed ID: 25797258
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor-induced COX-2 regulates metastasis of head and neck squamous cell carcinoma through upregulation of angiopoietin-like 4.
Chiang KH; Shieh JM; Shen CJ; Chang TW; Wu PT; Hsu JY; Tsai JP; Chang WC; Chen BK
Cancer Sci; 2020 Jun; 111(6):2004-2015. PubMed ID: 32227417
[TBL] [Abstract][Full Text] [Related]
7. 5'-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells.
Shi E; Wu Z; Karaoglan BS; Schwenk-Zieger S; Kranz G; Abdul Razak N; Reichel CA; Canis M; Baumeister P; Zeidler R; Gires O
J Biomed Sci; 2023 Aug; 30(1):72. PubMed ID: 37620936
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor-induced ANGPTL4 enhances anoikis resistance and tumour metastasis in head and neck squamous cell carcinoma.
Liao YH; Chiang KH; Shieh JM; Huang CR; Shen CJ; Huang WC; Chen BK
Oncogene; 2017 Apr; 36(16):2228-2242. PubMed ID: 27797381
[TBL] [Abstract][Full Text] [Related]
9. Functional Role of DUSP6 in the EGFR-mediated Progression of Head and Neck Squamous Cell Carcinoma.
Tai CH; Wang CC; Shih YC; Chen YJ; Chen BK; Chen LC
Anticancer Res; 2024 Jun; 44(6):2545-2554. PubMed ID: 38821599
[TBL] [Abstract][Full Text] [Related]
10. Role of GRB2-associated binder 1 in epidermal growth factor receptor-induced signaling in head and neck squamous cell carcinoma.
Hoeben A; Martin D; Clement PM; Cools J; Gutkind JS
Int J Cancer; 2013 Mar; 132(5):1042-50. PubMed ID: 22865653
[TBL] [Abstract][Full Text] [Related]
11. Oleic acid-induced ANGPTL4 enhances head and neck squamous cell carcinoma anoikis resistance and metastasis via up-regulation of fibronectin.
Shen CJ; Chan SH; Lee CT; Huang WC; Tsai JP; Chen BK
Cancer Lett; 2017 Feb; 386():110-122. PubMed ID: 27865799
[TBL] [Abstract][Full Text] [Related]
12. A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
Schinke H; Shi E; Lin Z; Quadt T; Kranz G; Zhou J; Wang H; Hess J; Heuer S; Belka C; Zitzelsberger H; Schumacher U; Genduso S; Riecken K; Gao Y; Wu Z; Reichel CA; Walz C; Canis M; Unger K; Baumeister P; Pan M; Gires O
Mol Cancer; 2022 Sep; 21(1):178. PubMed ID: 36076232
[TBL] [Abstract][Full Text] [Related]
13. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
[TBL] [Abstract][Full Text] [Related]
14. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
[TBL] [Abstract][Full Text] [Related]
15. Grape seed proanthocyanidins inhibit the invasive potential of head and neck cutaneous squamous cell carcinoma cells by targeting EGFR expression and epithelial-to-mesenchymal transition.
Sun Q; Prasad R; Rosenthal E; Katiyar SK
BMC Complement Altern Med; 2011 Dec; 11():134. PubMed ID: 22188922
[TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of EMMPRIN and epidermal growth factor receptor prevents the growth and migration of head and neck squamous cell carcinoma cells.
Suzuki S; Ishikawa K
Int J Oncol; 2014 Mar; 44(3):912-7. PubMed ID: 24379084
[TBL] [Abstract][Full Text] [Related]
17. Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.
Li Z; Liao J; Yang Z; Choi EY; Lapidus RG; Liu X; Cullen KJ; Dan H
Br J Cancer; 2019 Feb; 120(3):306-316. PubMed ID: 30585254
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways.
Pickhard AC; Margraf J; Knopf A; Stark T; Piontek G; Beck C; Boulesteix AL; Scherer EQ; Pigorsch S; Schlegel J; Arnold W; Reiter R
BMC Cancer; 2011 Sep; 11():388. PubMed ID: 21896192
[TBL] [Abstract][Full Text] [Related]
19. EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy.
Liu S; Wang Y; Han Y; Xia W; Zhang L; Xu S; Ju H; Zhang X; Ren G; Liu L; Ye W; Zhang Z; Hu J
Theranostics; 2020; 10(23):10589-10605. PubMed ID: 32929368
[No Abstract] [Full Text] [Related]
20. A novel diphtheria toxin-based bivalent human EGF fusion toxin for treatment of head and neck squamous cell carcinoma.
Qi Z; Qiu Y; Wang Z; Zhang H; Lu L; Liu Y; Mathes D; Pomfret EA; Gao D; Lu SL; Wang Z
Mol Oncol; 2021 Apr; 15(4):1054-1068. PubMed ID: 33540470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]